-
Measuring Drug Responses in Cancer In Vitro
2026-08-25
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchanged measures capture different relationships between growth inhibition and cell death. The framework supports more precise cancer research workflows by treating response magnitude, composition, and timing as separate experimental variables.
-
Angiotensin II, Ferroptosis, and NPC Radioresistance
2026-08-25
The reference study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses radiation-induced ferroptosis and promotes radioresistance in nasopharyngeal carcinoma. Its combination of mechanistic assays, radioresistant cell models, and xenograft validation supports angiotensin receptor blockade plus ferroptosis induction as a testable radiosensitization strategy, while highlighting candidate biomarkers for treatment response.
-
Azathramycin A: From Ribosome Binding to Translation
2026-08-24
A translational framework for using Azathramycin A to connect M. tuberculosis ribosome binding, protein synthesis inhibition, assay validation, degradation-product control, and antibiotic resistance research.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-08-24
The Tricine-SDS-PAGE Gel Preparation Kit is designed for high-resolution protein electrophoresis and peptide separation in the low-molecular-weight range, including targets from 1–10 kDa and peptides reported as small as 1.2 kDa. It is intended for research workflows such as denaturing or non-denaturing electrophoresis, not diagnostic, clinical, or medical testing.
-
SAH as a Translational Probe in Neural Radiation Biology
2026-08-23
S-Adenosylhomocysteine (SAH) offers a mechanistically grounded way to test whether methylation potential influences radiation-altered neuronal differentiation. This thought-leadership guide connects the SAM/SAH ratio to PI3K-STAT3-mGluR1 and p53 signaling while distinguishing established evidence from translational hypotheses.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-08-22
The reference study presents a genetically engineered, drug-sensitized yeast platform that detects TOR inhibitors at substantially lower concentrations than a wild-type background. Its results distinguish compounds with TOR1-dependent activity from tested molecules without detectable TOR pathway effects, including canagliflozin, providing a practical framework for early geroprotector and anticancer drug discovery.
-
Cabazitaxel (XRP6258) Protocol Guide
2026-08-22
Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxane derivative for studying microtubule dynamics disruption in cancer models, including P-glycoprotein-expressing and taxane-resistant cell lines. It is intended for carefully controlled DMSO- or ethanol-based workflows, is insoluble in water, and should not be kept as a long-term solution.
-
Gastrin I (human): Mechanism and GI Research
2026-08-21
Gastrin I is a human Gastrin I peptide that activates CCK2 receptor signaling associated with gastric acid secretion. This article defines its mechanistic use, product-handling parameters, and limits when extending gastric models to hiPSC-derived intestinal organoids.
-
Verteporfin Workflows for PDT and Autophagy Studies
2026-08-20
Build more informative Verteporfin experiments by separating light-dependent cytotoxicity from light-independent autophagy effects. This workflow connects ocular photodynamic therapy, apoptosis and chromatin-focused stem-cell assays while emphasizing controls, dosing discipline and troubleshooting.
-
Isoproterenol Sulfate Dihydrate in Neurocardiac Assays
2026-08-20
Isoproterenol sulfate dihydrate provides a controlled beta-adrenergic challenge for separating pacemaker maturation from acute neurocardiac responsiveness. This article translates recent SAN-plexus assembloid findings into assay-design principles for rigorous cardiovascular research.
-
Capsazepine: From TRPV1 Mechanism to Translation
2026-08-19
A thought-leadership perspective on using Capsazepine to dissect TRPV1 biology, interpret cross-channel pharmacology, improve sensory pain assays, and build a more disciplined translational evidence package spanning nociception and exploratory apoptosis research.
-
4-Ethylphenyl Sulfate: Applied Research Workflows
2026-08-19
Use 4-ethylphenyl sulfate as a chemically defined perturbation for gut-brain studies, an analytical target in renal dysfunction biomarker workflows, and a test analyte for magnetic adsorbent screening. This guide connects practical sample handling with behavioral, mass-spectrometric, and cyclodextrin-based adsorption assays while emphasizing controls and troubleshooting.
-
Epinephrine Bitartrate: From Receptor Signal to PK Design
2026-08-18
Epinephrine Bitartrate is a versatile adrenergic receptor agonist for studying integrated α- and β-receptor signaling. This article connects receptor pharmacology with route-dependent pharmacokinetics to improve translational assay design and interpretation.
-
PreScission Protease for Condensate Workflows
2026-08-18
PreScission Protease combines HRV 3C protease specificity with low-temperature tag removal for sensitive recombinant proteins. This guide shows how to adapt it for dKeap1 condensate studies, where residual tags, cleavage scars, and temperature shifts can alter phase behavior.
-
YM 58483 (BTP2) SOCE Blocker Guide
2026-08-17
This scenario-based guide explains how YM 58483 (BTP2), a store-operated Ca2+ entry (SOCE) blocker, can clarify calcium-dependent effects in T-cell, viability, proliferation, cytotoxicity, and fibrosis assays. It covers mechanism, assay compatibility, stock preparation, data interpretation, and vendor-selection considerations for SKU B7542.